Low dose arsenic-induced transient p53 inhibition: A novel strategy for chemotherapy protection

被引：0
|
作者：
Ganapathy, Suthakar [1 ]
Seog-Jin, Seo [1 ]
Ha, Chul Soo [1 ]
Yuan, Zhi-Min [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4317
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4317
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Arsenic-induced S phase cell cycle lengthening is associated with ROS generation, p53 signaling and CDC25A expression
    Pozo-Molina, Glustein
    Ponciano-Gomez, Alberto
    Cipactl Rivera-Gonzalez, Guillermo
    Hernandez-Zavala, Araceli
    Garrido, Efrain
    CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 238 : 170 - 179
  • [12] Involvement of a AS3MT/c-Fos/p53 signaling axis in arsenic-induced tumor in human lung cells
    Sun, Mingjun
    Cheng, Huirong
    Yu, Tianle
    Tan, Jingwen
    Li, Ming
    Chen, Qian
    Gu, Yun
    Jiang, Chenglan
    Li, Shuting
    He, Yuefeng
    Wen, Weihua
    ENVIRONMENTAL TOXICOLOGY, 2023, 38 (03) : 615 - 627
  • [13] p53 is essential for chemotherapy-induced hair loss
    Botchkarev, VA
    Komarova, EA
    Siebenhaar, F
    Botchkareva, NV
    Komarov, PG
    Maurer, M
    Gilchrest, BA
    Gudkov, AV
    CANCER RESEARCH, 2000, 60 (18) : 5002 - 5006
  • [14] LincRNAs and base modifications of p53 induced by arsenic methylation in workers
    Wen, Weihua
    Lu, Lin
    He, Yuefeng
    Cheng, Huirong
    He, Fang
    Cao, Shuqiao
    Li, Liang
    Xiong, Li
    Wu, Tangchun
    CHEMICO-BIOLOGICAL INTERACTIONS, 2016, 246 : 1 - 10
  • [15] Mutant p53 reactivation as a novel strategy for cancer therapy
    Wiman, KG
    Stridh, H
    Zache, N
    Rökaeus, N
    Issaeva, N
    Hammarsund, M
    Shen, JF
    Bergman, J
    Westman, J
    Selivanova, G
    Bykov, VJN
    ANNALS OF ONCOLOGY, 2005, 16 : 23 - 24
  • [16] Arsenic-induced apoptosis in the p53-proficient and p53-deficient cells through differential modulation of NFkB pathway
    Yin, Lei
    Yu, Xiaozhong
    FOOD AND CHEMICAL TOXICOLOGY, 2018, 118 : 849 - 860
  • [17] Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
    Sarah E. Woodfield
    Yan Shi
    Roma H. Patel
    Zhenghu Chen
    Aayushi P. Shah
    Rohit K. Srivastava
    Richard S. Whitlock
    Aryana M. Ibarra
    Samuel R. Larson
    Stephen F. Sarabia
    Andrew Badachhape
    Zbigniew Starosolski
    Ketan B. Ghaghada
    Pavel Sumazin
    D. Allen Annis
    Dolores López-Terrada
    Sanjeev A. Vasudevan
    Scientific Reports, 11
  • [18] PUMA, a novel proapoptotic gene, is induced by p53
    Nakano, K
    Vousden, KH
    MOLECULAR CELL, 2001, 7 (03) : 683 - 694
  • [19] Arsenic-induced downregulation of BRWD3 suppresses proliferation and induces apoptosis in lung adenocarcinoma cells through the p53 and p65 pathways
    Zhu, Yanhua
    Xiao, Mei
    Zhao, Ruihuan
    Yang, Xuefei
    Wu, Kun
    Liu, Xiao
    Chen, Xi
    Guo, Lei
    Liu, Jiezhen
    Chen, Xu
    Liu, Na
    He, Yuefeng
    Zhang, Yanliang
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2024, 43
  • [20] Specific activation of the p53 pathway by low dose actinomycin D A new route to p53 based cyclotherapy
    Choong, Meng Ling
    Yang, Henry
    Lee, May Ann
    Lane, David P.
    CELL CYCLE, 2009, 8 (17) : 2810 - 2818
12345